We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gen-Probe has announced that bioMerieux has exercised an option to develop diagnostic
products for certain undisclosed disease targets using Gen-Probe's patented
ribosomal RNA technologies, pursuant to terms of an agreement first disclosed
Oct. 6, 2004.
CalbaTech, a life sciences company concentrating on providing products and platforms
to the research market for biotech and pharmaceutical companies and to academic
institutions, announced that its wholly owned subsidiary, LifeStem, launched
a major project to develop its Stem Cell Delivery Device.
Sorin, a European medical technology company specializing in the treatment of
cardiovascular diseases, has completed enrollment of its JUPITER II clinical
trial.
A noninvasive fingertip test can identify coronary disease at its earliest stages
and may provide an easy to use tool for daily clinical practice, according to
a recent study published in the Journal of the American College of Cardiology.
Lifestream Technologies, a supplier of cholesterol monitors, has unveiled a
concept product at the recent FDA hearing on an OTC petition for a cholesterol
lowering drug.
ORTHOsoft, a developer of computer-assisted orthopedic surgery technology, has
announced that its Navitrack Navigation System is now available and successfully
being used by a number of Tampa-area surgeons, hospitals and surgery centers
to optimize the results of total knee and total hip replacements.
OctoPlus has raised $23.85 million in a second financing round from an international
group of investors. The investment was led by Life Sciences Partners and S.R.
One.